HRP20140808T1 - Fosfaplatine i njihova uporaba za lijeäśenje raka rezistentnog na cisplantin i karboplatin - Google Patents

Fosfaplatine i njihova uporaba za lijeäśenje raka rezistentnog na cisplantin i karboplatin Download PDF

Info

Publication number
HRP20140808T1
HRP20140808T1 HRP20140808AT HRP20140808T HRP20140808T1 HR P20140808 T1 HRP20140808 T1 HR P20140808T1 HR P20140808A T HRP20140808A T HR P20140808AT HR P20140808 T HRP20140808 T HR P20140808T HR P20140808 T1 HRP20140808 T1 HR P20140808T1
Authority
HR
Croatia
Prior art keywords
platinum
trans
isolated
preparation
complex
Prior art date
Application number
HRP20140808AT
Other languages
English (en)
Croatian (hr)
Inventor
Rathindra N. Bose
Original Assignee
Ohio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio University filed Critical Ohio University
Publication of HRP20140808T1 publication Critical patent/HRP20140808T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20140808AT 2007-08-06 2008-08-06 Fosfaplatine i njihova uporaba za lijeäśenje raka rezistentnog na cisplantin i karboplatin HRP20140808T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95412607P 2007-08-06 2007-08-06
US97392607P 2007-09-20 2007-09-20
PCT/US2008/072398 WO2009021082A2 (en) 2007-08-06 2008-08-06 Phosphaplatins and their use in the treatment of cancers resistant to cisplantin and carboplatin

Publications (1)

Publication Number Publication Date
HRP20140808T1 true HRP20140808T1 (hr) 2014-10-24

Family

ID=40342030

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20140808AT HRP20140808T1 (hr) 2007-08-06 2008-08-06 Fosfaplatine i njihova uporaba za lijeäśenje raka rezistentnog na cisplantin i karboplatin

Country Status (12)

Country Link
US (4) US7700649B2 (https=)
EP (2) EP2668949A1 (https=)
JP (2) JP5385274B2 (https=)
CN (1) CN101801369B (https=)
CY (1) CY1115504T1 (https=)
DK (1) DK2173337T3 (https=)
ES (1) ES2495743T3 (https=)
HR (1) HRP20140808T1 (https=)
PL (1) PL2173337T3 (https=)
PT (1) PT2173337E (https=)
SI (1) SI2173337T1 (https=)
WO (2) WO2009021081A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2495743T3 (es) * 2007-08-06 2014-09-17 Ohio University Fosfaplatinos y su uso en el tratamiento de cánceres resistentes a cisplatino y carboplatino
CN108210516A (zh) * 2010-06-04 2018-06-29 俄亥俄大学 磷铂及其在治疗癌症中的用途
US20130236568A1 (en) 2011-01-12 2013-09-12 Ohio University Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
EP2729526B1 (en) 2011-07-08 2017-10-04 Dow Global Technologies LLC Polyethylene blend composition suitable for blown film, method of producing the same, and films made therefrom
JP6027619B2 (ja) 2011-10-05 2016-11-16 ラシンドラ・エヌ・ボーズ ホスファプラチン系抗腫瘍剤の大規模調製のための効率的プロセス
WO2013052839A1 (en) 2011-10-05 2013-04-11 Bose Rathindra N Efficient processes for large scale preparation of phosphaplatins antitumor agents
MX365635B (es) 2011-10-20 2019-06-10 Nerium Biotechnology Inc Combinacion terapeutica para el tratamiento de cancer.
LT2855496T (lt) * 2012-05-24 2017-04-10 Phosplatin Therapeutics Llc Fosfaplatinos junginių sintezės ir gryninimo būdai ir jų panaudojimas
EP2958568B1 (en) * 2013-02-22 2020-03-04 University Of Houston Phosphaplatins as neuroprotective agents
WO2015127037A1 (en) * 2014-02-19 2015-08-27 University Of Houston System Compositions and methods for the treatment of neurodegenerative diseases
MX370673B (es) 2014-06-11 2019-12-19 Univ Texas Conjugados y composiciones de texafirina-pt (iv) para su uso para superar la resistencia del platino.
EP3397642A1 (en) 2015-12-30 2018-11-07 Atilim Universitesi Dna targeted mono and heterodinuclear complexes
TWI791008B (zh) 2017-01-06 2023-02-01 美商弗斯普萊汀治療股份有限公司 作為供骨癌或血癌治療用之治療劑的磷酸鉑(phosphaplatin)化合物
JP7381083B2 (ja) 2017-09-08 2023-11-15 フォスプラティン テラピューティクス インコーポレイテッド 免疫調節剤としてのホスファプラチン化合物およびその治療的使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291027A (en) 1979-03-07 1981-09-22 Engelhard Minerals & Chemicals Corp. Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
US4234500A (en) * 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
CA2017739A1 (en) * 1989-07-18 1991-01-18 Engelhard Corporation Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
EP1644388A2 (en) * 2003-06-27 2006-04-12 ODANI, Akira Bisphosphonate complexes
EP2177525A1 (en) * 2007-07-06 2010-04-21 TMRC Co., Ltd. Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound
ES2495743T3 (es) * 2007-08-06 2014-09-17 Ohio University Fosfaplatinos y su uso en el tratamiento de cánceres resistentes a cisplatino y carboplatino

Also Published As

Publication number Publication date
SI2173337T1 (sl) 2014-10-30
US8034964B2 (en) 2011-10-11
CY1115504T1 (el) 2017-01-04
US20110313182A1 (en) 2011-12-22
WO2009021082A3 (en) 2009-04-23
US20090042838A1 (en) 2009-02-12
JP5385274B2 (ja) 2014-01-08
WO2009021081A3 (en) 2009-05-07
PL2173337T3 (pl) 2014-11-28
ES2495743T3 (es) 2014-09-17
WO2009021081A2 (en) 2009-02-12
US20130237503A1 (en) 2013-09-12
CN101801369B (zh) 2012-09-19
HK1143551A1 (en) 2011-01-07
WO2009021082A2 (en) 2009-02-12
EP2173337A4 (en) 2010-10-27
EP2173337A2 (en) 2010-04-14
US20100233293A1 (en) 2010-09-16
JP2010535803A (ja) 2010-11-25
US7700649B2 (en) 2010-04-20
EP2668949A1 (en) 2013-12-04
EP2173337B1 (en) 2014-07-30
CN101801369A (zh) 2010-08-11
US8653132B2 (en) 2014-02-18
JP5647300B2 (ja) 2014-12-24
JP2013227218A (ja) 2013-11-07
US8445710B2 (en) 2013-05-21
PT2173337E (pt) 2014-09-03
DK2173337T3 (da) 2014-09-15

Similar Documents

Publication Publication Date Title
HRP20140808T1 (hr) Fosfaplatine i njihova uporaba za lijeäśenje raka rezistentnog na cisplantin i karboplatin
CN104561974B (zh) 一种电镀锌钢板无铬钝化液及其制备方法
JP2008538743A5 (https=)
CN102766150B (zh) 含有季铵盐的可聚合水杨醛配合物及其制备方法
JP2013227218A5 (https=)
CN107829080B (zh) 一种锌锰系磷化液及其制备方法
CN100453703C (zh) 一种控制二氧化碳腐蚀的缓蚀剂及其制备方法
HRP20170416T1 (hr) Sintetski postupci i postupci pročišćavanja spojeva fosfaplatine i njihova uporaba
EP2336139A3 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
CN101935094B (zh) 一种活性染料废水絮凝脱色剂的制备方法
JPH02255876A (ja) 耐水性を有するインキ組成物
WO2026037065A1 (zh) 一种脲酶抑制剂及其在农作物种植中的应用
CN104045683A (zh) 基于金属铱配合物的多肽荧光环化方法及环化多肽
MX2016006412A (es) Composicion acuosa de recubrimiento por inmersion que comprende bismuto disuelto, para sustratos conductores de electricidad.
CN106634216B (zh) 一种储存稳定的高耐候性水性陶瓷渗花墨水及其制法
CN104151331A (zh) 具有抑制脲酶活性的金属配合物及其制备方法和用途
CN105683748A (zh) 甲醛测试试剂
WO2006001378A1 (ja) Ｌ－オルニチン・クエン酸塩結晶
CN103992355A (zh) 钴四元配合物[Co(4,4’-bpt)2(O-BDC)(H2O)3]NO3·H2O及其制备方法
CN104447429A (zh) 环保酸性可拔色黄色染料化合物、应用及合成方法
RU2535834C2 (ru) Способ получения фосфатов никеля(ii)-аммония
CN101301617A (zh) 用于分解磷化氢制备单质磷的负载型催化剂及其制备方法
RU2613838C1 (ru) Щавелевокислый электролит для осаждения сплава медь-олово
CN107266491A (zh) 易降解磷酸盐型阴离子双子表面活性剂及其制备方法和应用
CN105237553A (zh) 单核吡唑-4-甲酸锌配合物及其制备方法